A pain-predominant phenotype was identified in 6.9% of patients diagnosed with dry eye disease, characterized by severe symptoms despite minimal signs, strong associations with migraine and psychiatric disorders, and lower prevalence of autoimmune conditions.
Quick Take
A distinct pain-predominant phenotype has been identified in 6.9% of dry eye disease patients, characterized by a significant mismatch where severe symptoms persist despite minimal clinical signs. This specific subgroup is more closely linked to systemic comorbidities like migraines and psychiatric disorders than to traditional autoimmune-related ocular surface disease.
Why It Matters
The 'sign-symptom mismatch' is one of the most challenging aspects of dry eye management, often leading to patient frustration and perceived treatment failure. By quantifying this 6.9% phenotype, the study provides a clinical framework for identifying patients whose ocular pain may be driven by centralized or neuropathic mechanisms rather than tear film instability. Recognizing this early allows clinicians to pivot from standard topical lubricants toward multidisciplinary care involving pain management or neurology.
Key Findings
Study Snapshot
Design
Phenotype identification study
Population
Patients diagnosed with dry eye disease
Practice Implications
When clinical findings like staining or tear breakup time do not match a patient's high level of reported pain, clinicians should screen for a history of migraines or psychiatric conditions. For this 6.9% of the population, escalating traditional ocular surface treatments may be less effective than addressing the underlying pain phenotype or systemic associations.
Who's Affected
AI-generated summary — always read the original source for full context
No comments yet. Be the first to share your thoughts.
